본문

  1. Home
6 Results:AA:PH D PP:ELSEVIER INC 0.140 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
1
Bisphosphonates do not alter the rate of secondary mineralization
Bisphosphonates do not alter the rate of secondary mineralization
Fuchs, R. K, | Elsevier Inc | 2011 ,
2
Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral
Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral
Paschalis, E. P, | Elsevier Inc | 2011 ,
3
Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
Gamsjaeger, S, | Elsevier Inc | 2011 ,
4
Treatment and prevention of bone complications from prostate cancer.
Treatment and prevention of bone complications from prostate cancer.
Richard J Lee,, | Elsevier Inc | 2011 ,
5
Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
Philippe Clézardin, | Elsevier Inc | 2011 ,
6
Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
Allen, M. R., | Elsevier Inc | 2011 ,
처음1마지막